Ocean Biomedical, Inc. (OCEA) stock
OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026Market cap $45.51KP/E –Yield –
Ocean Biomedical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Ocean Biomedical's operating income for the twelve months ending Mar 31, 2025 was -$4.16M. For fiscal 2024 it was -$3.80M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$3.80M | – |
| FY2023 | Dec 31, 2023 | -$10.21M | – |
| FY2022 | Dec 31, 2022 | -$16.12M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | -$958.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.75M | -365.6% |
| Q3 FY2024 | Sep 30, 2024 | -$768.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$682.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$595.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $660.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.66M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.83M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.39M | – |
| Q4 FY2022 | Dec 31, 2022 | -$938.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.17M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.90M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.11M | – |
| Q3 FY2021 | Sep 30, 2021 | -$42.80K | – |
See a number that looks wrong?